Development of Continuous Assessment of Frailty and Muscle Quality in Older Subjects: ECOFRAIL Protocol
ECOFRAIL
1 other identifier
interventional
85
1 country
3
Brief Summary
We are conducting a study in different centers in Spain in elderly people, in order to assess the effectiveness of a physical exercise intervention program in people in a situation of frailty. Frailty in an elderly person is a situation in which, although there are no major differences in their usual abilities, the person presents a certain decrease in their capacities. This slight decrease is usually accompanied by a progressive deterioration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2022
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 15, 2022
CompletedFirst Posted
Study publicly available on registry
March 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedMay 4, 2026
September 1, 2023
2.3 years
March 15, 2022
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Biomarker - Quality of Life - Muscle mass
Association between quantitative ultrasound biomarkers associated to muscle mass and quality and extracted from raw data and blood-based biomarkers and combinations thereof with clinical variables including frailty, sarcopenia, physical function, disability, nutritional status, body composition, and Quality of Life in three cohorts of older adults: hospital control cohort, hospital exercise cohort, and primary care cohort. Muscle quality and mass: Ultrasound. Thickness (mm), cross-sectional area (cm²), perimeter (mm) and pennation angle (°). Frailty: FRAIL scale range 0-5. Frailty phenotype (0-5). Sarcopenia: SARC-F scale (0-10). Disability: GDS, 7 stages. Barthel index (0-100). Lawton and Brody index 0-8. Physical function: SPPB (0-12). IPAQ (0-3). Gait speed test, seconds. Grip strength, Jamar dynamometer, kilograms. Quality of life: EQ 5D-5L, scale of 0-100. Blood biomarkers: Vitamin D, Lutein zeaxanthin, Troponin T, Pro-BNP, and sRAGE with ELISA, miRNAs (qRT-PCR).
2 years
Study Arms (3)
Hospital control
NO INTERVENTIONHospital control cohort: Participants will be consecutively recruited from the scheduled patient list of the frailty unit, day hospital, and the outpatient clinic of the Geriatrics Department of Hospital 2. After obtaining informed consent, baseline study variables will be collected. Patients will be followed-up for a 16-week period, under usual care. After the follow-up period, baseline evaluation will be repeated.
Exercise
EXPERIMENTALElderly people without muscle problems participating in the exercise program to see improvements in their muscle mass levels and quality
Primary care Control
NO INTERVENTIONPrimary care cohort: Participants will be consecutively recruited from the scheduled patient list of the Primary Care Units. After informed consent acquisition, baseline study variables will be collected. Patients will be followed-up during one year, under usual care. After the one-year follow-up, the baseline evaluation will be repeated.
Interventions
1\. Hospital exercise cohort: Participants will be consecutively recruited from the scheduled patient list of the falls unit and the outpatient clinics of Hospital 1. After informed consent acquisition, patients will receive a baseline clinical evaluation. Ultrasound measurements and DXA scan will be conducted, and blood samples will be collected, processed, and stored. Patients will be included in the 16-week multicomponent physical exercise program described below. After the completion of the exercise program, at 16-week follow-up, clinical evaluation, ultrasound, DXA, and blood-sample testing will be repeated.
Eligibility Criteria
You may qualify if:
- Age of at least 70 years old.
- Either gender.
- Ability to provide informed consent.
- Ability to perform all the functional tests.
- In the hospital exercise cohort, ability to perform the physical exercise program.
You may not qualify if:
- Expected survival inferior to one year.
- Barthel scale \< 70.
- Moderate to severe cognitive impairment.
- Refuse to participate.
- Medical conditions that may condition or difficult the follow-up assessments.
- Older adults already included in regular physical exercise programmes will be excluded to participate in the hospital exercise cohort.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- European University of Vitoria-Gasteizcollaborator
- Hospital Universitario Getafecollaborator
- Biogipuzkoa Health Research Institutecollaborator
- University of Deustolead
- Complejo Hospitalario Universitario de Albacetecollaborator
Study Sites (3)
Complejo Hospitalario Universitario de Albacete
Albacete, Castille-La Mancha, 02006, Spain
Donostialdea, Osakidetza
Donostia / San Sebastian, Spain
Hospital Universitario de Getafe
Getafe, Spain
Related Publications (1)
Virto N, Rio X, Angulo-Garay G, Garcia Molina R, Avendano Cespedes A, Cortes Zamora EB, Gomez Jimenez E, Alcantud Corcoles R, Rodriguez Manas L, Costa-Grille A, Matheu A, Marcos-Perez D, Lazcano U, Vergara I, Arjona L, Saeteros M, Lopez-de-Ipina D, Coca A, Abizanda Soler P, Sanabria SJ. Development of Continuous Assessment of Muscle Quality and Frailty in Older Patients Using Multiparametric Combinations of Ultrasound and Blood Biomarkers: Protocol for the ECOFRAIL Study. JMIR Res Protoc. 2024 Feb 23;13:e50325. doi: 10.2196/50325.
PMID: 38393761DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sergio Sanabria, Ph.D.
University of Deusto
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher HealthPASS team
Study Record Dates
First Submitted
March 15, 2022
First Posted
March 24, 2022
Study Start
March 1, 2022
Primary Completion
June 30, 2024
Study Completion
June 30, 2024
Last Updated
May 4, 2026
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share